INTELLIPLEX
Live / Registered — Registered (as of 24 Aug 2021)
What this means for you
Registered since 24 Aug 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90221722
- Registration number
- 6459864
- Mark type
- Stylized text
- Filed
- 29 Sept 2020
- Published for opposition
- 08 Jun 2021
- Registered
- 24 Aug 2021
- Attorney of record
- Charles P. Guarino
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic test reagents for medical purposes
- Class 010 — Medical apparatus: Testing apparatus for medical purposes, namely, DNA and RNA testing apparatus, and medical diagnostic testing apparatus using blood, urine, other body fluids or tissue slices taken from the human body for in vitro tests and analysis; Apparatus for use in medical analysis, namely, apparatus for blood analysis, body composition analyzers for medical purposes, medical instruments for analyzing and identifying bacteria, apparatus for analyzing blood vessels, apparatus for cavitation detecting, and medical image processors
Owner
- PLEXBIO CO., LTD, Taipei City, TW
- PLEXBIO CO., LTD, Taipei City, TW
- PLEXBIO CO., LTD, Taipei City, TW
Prosecution history
- 24 Aug 2021 — REGISTERED-PRINCIPAL REGISTER
- 08 Jun 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jun 2021 — PUBLISHED FOR OPPOSITION
- 19 May 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 May 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Apr 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Apr 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Apr 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Mar 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Mar 2021 — NON-FINAL ACTION E-MAILED
- 31 Mar 2021 — NON-FINAL ACTION WRITTEN
- 30 Mar 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Mar 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Mar 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Feb 2021 — NOTIFICATION OF PRIORITY ACTION E-MAILED